Key points are not available for this paper at this time.
as a therapeutically relevant probiotic bacterium that might be employed in patients with inflammatory bowel disease (IBD).
Krause et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: